Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06633276 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fast and Accurate Breast Cancer Diagnosis Using Nanopore Sequencing in Tanzania (Fast-ABCD Sequencing)

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 8 months later Apr 2026 → Dec 31, 2026
See other at-risk trials from University of Bonn

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Apr 2026 to Dec 31, 2026 Show 4 more changesShow less
    • Start date changed from estimate of May 2025 to Sep 30, 2025
    • Study completion pushed from May 2026 to May 2027
    • Secondary endpoints revised (2)
    • Eligibility criteria expanded, about 5 words
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Study completion date: Apr 2026 to May 2026
    • Start date: Apr 2025 to May 2025
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints revised (2)
    • Site details revised
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
University of Bonn
17 trials monitored
See 1 trial at risk
Breast Cancer
5,418 trials monitored
See 296 trials at risk
This pilot study will test the feasibility of using nanopore sequencing for breast cancer diagnosis in Tanzania. It aims to show that nanopore sequencing is non-inferior to the current standard of care, with the potential for faster and more cost-efficient results. By enhancing the speed and accuracy of diagnosis, this approach could improve treatment planning and outcomes for patients in resource-limited settings.
Trial Details
NCT Number NCT06633276
Lead Sponsor University of Bonn
Collaborators: German Cancer Research Center, Kilimanjaro Christian Medical Centre,Moshi,Tanzania
Conditions
(from sponsor)		 Breast Cancer Invasive
Related terms Breast Neoplasms
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov